Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Glimepiride (4mg) + Metformin (1000mg) SR Bilayered Smart Tablet
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹224/-
Gimtype M4 Forte is a bilayered smart tablet specifically formulated for the effective management of type 2 diabetes mellitus. This advanced formulation combines two powerful active ingredients: Glimepiride (4 mg) and Metformin (1000 mg) sustained release (SR). Together, these components provide a comprehensive approach to controlling blood glucose levels, making it an essential option for patients with diabetes. Glimepiride, a member of the sulfonylurea class, works by stimulating the pancreas to produce more insulin, which is crucial for lowering blood sugar levels. This action is particularly effective in managing postprandial glucose levels. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity in peripheral tissues and reduces hepatic glucose production. The sustained release formulation of Metformin ensures a gradual release of the medication, helping to maintain stable blood glucose levels throughout the day while minimizing gastrointestinal side effects. The combination of Glimepiride and Metformin in Gimtype M4 Forte not only aids in achieving better glycemic control but also helps in reducing the risk of diabetes-related complications. This dual-action approach is especially beneficial for patients who may not achieve adequate control with Metformin alone. By addressing multiple mechanisms involved in glucose regulation, Gimtype M4 Forte provides a more effective solution for managing type 2 diabetes.
Gimtype M4 Forte is a bilayered smart tablet specifically formulated for the effective management of type 2 diabetes mellitus. This advanced formulation combines two powerful active ingredients: Glimepiride (4 mg) and Metformin (1000 mg) sustained release (SR). Together, these components provide a comprehensive approach to controlling blood glucose levels, making it an essential option for patients with diabetes.
Glimepiride, a member of the sulfonylurea class, works by stimulating the pancreas to produce more insulin, which is crucial for lowering blood sugar levels. This action is particularly effective in managing postprandial glucose levels. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity in peripheral tissues and reduces hepatic glucose production. The sustained release formulation of Metformin ensures a gradual release of the medication, helping to maintain stable blood glucose levels throughout the day while minimizing gastrointestinal side effects.
The combination of Glimepiride and Metformin in Gimtype M4 Forte not only aids in achieving better glycemic control but also helps in reducing the risk of diabetes-related complications. This dual-action approach is especially beneficial for patients who may not achieve adequate control with Metformin alone. By addressing multiple mechanisms involved in glucose regulation, Gimtype M4 Forte provides a more effective solution for managing type 2 diabetes.
Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Hypoglycemia is also a risk, especially if meals are missed or if there is increased physical activity.
Gimtype M4 Forte is indicated for the management of type 2 diabetes mellitus, particularly in conjunction with diet and exercise
Consult your healthcare provider before starting this medication, especially if you have a history of kidney or liver disease.
Store Gimtype M4 Forte tablets in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Glibenclamide I.P. 5mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone Hydrochloride I.P. 15mg Tablets
Composition : Glimepiride (1mg) Tablet
Composition : Glimepiride (2mg) Tablet
Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Gliclazide 80mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Losartan 50mg + Amlodipine 5mg Tablet
Composition : LISINOPRIL 5 + AMLODIPINE 5 MG tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation